Cold Pain Therapy Market 2021 | CryoConcepts LP, Metrum Cryoflex, Brymill Cryogenic Systems

Cold pain therapy is a therapeutic use of cold that is used to treat acute soft tissue injuries, decrease pain in post-operative orthopedic procedures, treat benign and malignant lesions and control pain. Cryotherapy can be used topically (on the surface of the skin), surgically, or percutaneously (through the skin). Oral mucositis, skin tags, pre-cancerous skin moles, and injuries, tumors in the breast, lungs, skin, bone, kidney, and liver are among diseases that can be treated with Cryotherapy.

Get PDF Brochure Of This Report With Detailed Analysis @ https://www.coherentmarketinsights.com/insight/request-pdf/1162

Cryosurgery is a procedure that involves the eradication of abnormal tissues using severe cold generated by liquid nitrogen (or argon gas). Cryosurgery is used to treat a variety of cancers as well as certain non-cancerous diseases, according to the National Cancer Institute (NCI). Retinoblastoma, early-stage skin cancer, cervical intraepithelial neoplasia, and actinic keratosis have all been found to respond well to this therapy. Cryotherapy was shown to be beneficial in reducing the adverse effects of chemotherapy-induced peripheral neuropathy, according to research published in the Journal of the National Cancer Institute in October 2017.

Cryotherapy is defined as “super cooling” of bodily tissues for therapeutic purposes, according to the U.S. Food and Drug Administration. Furthermore, cryotherapy entails the use of ice packs to a specific area of the body, such as the lower back. Whole Body Cryotherapy (WBC) includes exposing the body to liquid nitrogen vapors to achieve an ultra-low temperature of -200 to -300 degrees Fahrenheit. For two to four minutes, WBCs are treated in relatively restricted areas or chambers. Moreover, The U.S. Food and Drug Administration (FDA) does not have enough data to suggest the use of WBC to treat diseases or illnesses such as stress, anxiety, multiple sclerosis, chronic pain, rheumatoid arthritis, and Alzheimer’s disease. The use of WBC carries a number of risks, such as frostbite, burns, and eye damage due to the low temperature.

During the forecast period, the key driving factors impacting the global cold pain therapy market growth are rising incidence of prostate, skin, cervical cancer, retinoblastoma, and other cancers, as well as the rising number of accidents and sports injuries. According to the Centers for Disease Control and Prevention (CDC), 12,578 women in the U.S. were diagnosed with cervical cancer in 2014, with 4,115 women dying from the disease. Furthermore, in 2014, Cancer Research UK recorded 3,224 new cervical cancer cases in the U.K.

Furthermore, the global cold pain treatment market is expected to witness growth due to an increase in work-related and sports-related injuries over the forecast period. According to the Health and Safety Executive (HSE), there were around 600,000 non-fatal workplace injuries recorded in 2016. Furthermore, new cases of work-related sickness cost the U.K US$ 12.4 billion in 2016. Moreover, according to the U.S. Bureau of Labor Statistics, private industry employees reported 2.9 million non-fatal workplace injuries and illnesses in 2016.

Global Cold Pain Therapy Market Taxonomy:

On the basis of product, global cold pain therapy market segmented into:

• OTC-based products
  • Pharmaceuticals
    • Gels, ointment and creams
    • Patches
    • Spray and foams
    • Roll-ons
  • Medical devices
    • Cold packs
    • Cooling pads, wraps, and pads
  • Prescription-based products
    • Motorized cryotherapy devices
    • Non-motorized cryotherapy devices

On the basis of therapy type, global cold pain therapy market segmented into:

• Cryosurgery
• Icepack therapy
• Chamber therapy

On the basis of device type, global cold pain therapy market segmented into:

• Spray cryogun
• Dipstick applicator
• Cryoprobe
• Other devices

On the basis of application, global cold pain therapy market segmented into:

• Dermatology
• Oncology
• Musculoskeletal disorder
• Pain management
• Sport medicine
• Physical therapy
• Ophthalmology
• Post-operative
• Post-trauma

On the basis of distribution channel, global cold pain therapy market segmented into:

• Online pharmacies
• Retail pharmacies
• Hospital pharmacies

SA Medical, Inc. obtained U.S. FDA approval in July 2017 to expand its truFreeze catheter product to provide the Rapid AV Spray Kit. The truFreeze system is used in cryosurgical operations for general surgery, dermatology, gynecology, and the elimination of malignant lesions. Furthermore, the integration of a fast AV Spray kit with a truFreeze catheter is intended to save surgical time and hence shorten overall patient treatment duration.

Buy This Research Study Report For Quick Access@ https://www.coherentmarketinsights.com/insight/buy-now/1162

PENTAX Medical acquired C2 Therapeutics in January 2017. PENTAX Medical is a business that specializes in the production, research, and development of endoscopic products and services. C2 Therapeutics develops the C2 CryoBalloon Ablation System, which is used for endoscopic tissue ablation. PENTAX Medical was also able to expand its therapeutic endoscopy product and service offering as a result of the acquisition.

Major players operating in the global cold pain therapy market include Special Medical Technology Co., Ltd, Brymill Cryogenic Systems, Cortex Technology, CooperSurgical Inc., Metrum, Wallach Surgical Devices, Erbe Elektromedizin, GmbH, Zimmer MedizinSystems, PHYSIOMED AG., CryoConcepts LP, Sanarus, Medtronic plc, Mectronic Mediccale S.r.l., Cryoflex, CSA Medical, Inc., and Galil Medical, Inc.

About Us: